杭州安杰思医学科技股份有限公司 2025年第二次临时股东大会决议公告

Core Viewpoint - The company held its second extraordinary general meeting of shareholders on September 26, 2025, where significant resolutions were passed, including the cancellation of the supervisory board and amendments to the company's articles of association [2][5][11]. Group 1: Meeting Details - The extraordinary general meeting was held on September 26, 2025, at the company's premises in Hangzhou [2]. - The total share capital as of the registration date for the meeting was 80,978,794 shares, with 20,475 shares in the company's repurchase account not entitled to vote [2]. - The meeting was chaired by the chairman of the board, Zhang Cheng, and utilized a combination of on-site and online voting methods [3][4]. Group 2: Resolutions Passed - The first resolution to cancel the supervisory board and amend the articles of association was approved with more than two-thirds of the voting rights present [5][6]. - The second resolution regarding the formulation, abolition, and revision of certain corporate governance systems was also passed [5][6]. - The board of directors confirmed the election of Zhang Cheng as the representative director of the company, with a term lasting until the end of the current board's term [11][12]. Group 3: Board Meeting Details - The third board meeting was held on the same day, September 26, 2025, with all five directors present [10]. - The board approved the election of Zhang Cheng as the legal representative of the company [11]. - The board also addressed the resignation of employee representative director Han Chunqi and elected Shi Baiming as a new member of the audit and remuneration committees [14][16].